© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

Top section

Top section

It's easy for investment bankers to get jaded about awards ceremonies, but they are missing the point
Investment bank, like the group, wants to diversify outside France, and will lead with its strongest suit, real assets
Real estate company follows Vinci's €500m five year exchangeable
More articles

More articles

More articles

  • China’s securities regulator is pushing for closer co-operation with the US Securities and Exchange Commission to support overseas listings.
  • Online music platform Cloud Village is drumming up demand for its Hong Kong listing, according to a source familiar with the matter.
  • TechnipFMC, the French-US energy technologies group, executed on Thursday night its second block sale of shares in Technip Energies, the engineering and construction subsidiary it span off in February. Despite the holiday season, the parent achieved a fractionally higher price than in the last trade and a significantly tighter discount.
  • Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times.
  • Chinese stocks were in freefall this week after Beijing tightened rules for the for-profit education sector, sparking a fresh — and severe — bout of volatility in the equities market. While the timing for new IPOs is far from ideal, there is hope yet for companies, say ECM bankers. Jonathan Breen reports.
  • HK Inno.N Corp, a South Korean pharmaceuticals company known for its popular hangover tonics, has priced its IPO at the top of the marketed range, netting W596.9bn ($520.9m).
shared comment list